BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11045340)

  • 1. The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications.
    Schaudig U; Maas R
    Graefes Arch Clin Exp Ophthalmol; 2000 Sep; 238(9):733-7. PubMed ID: 11045340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic findings after nasolacrimal polyurethane stent implantations.
    Lee JH; Kang MS; Yang JW
    Korean J Ophthalmol; 2005 Dec; 19(4):252-7. PubMed ID: 16491813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients with nasolacrimal polyurethane stent implantation: do they keep tearing?
    Oztürk S; Konuk O; Ilgit ET; Unal M; Erdem O
    Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):130-5. PubMed ID: 15083082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
    Yazici B; Yazici Z; Parlak M
    Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction.
    Lee JS; Jung G; Oum BS; Lee SH; Roh HJ
    Ophthalmology; 2000 Sep; 107(9):1666-70. PubMed ID: 10964826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasolacrimal polyurethane stent placement: preliminary results.
    Perena MF; Castillo J; Medrano J; De Gregorio MA; Loras E; Cristobal JA
    Eur J Ophthalmol; 2001; 11(1):25-30. PubMed ID: 11284481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nasolacrimal stent implantation: report of a case].
    Lunardelli P; Aoki L; Jervásio AC; Zagui RM; Matayoshi S
    Arq Bras Oftalmol; 2008; 71(1):110-4. PubMed ID: 18408851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Site of a polyurethane stent in dacryocystography. Is postoperative success hereby predictable?].
    Anders N; Hoffmann KT
    Ophthalmologe; 2000 Dec; 97(12):842-5. PubMed ID: 11227155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of complete and partial obstruction of the nasolacrimal system with polyurethane stents: initial experience.
    Pulido-Duque JM; Reyes R; Carreira JM; Vega F; Górriz E; Pardo MD; Perez F; Maynar M
    Cardiovasc Intervent Radiol; 1998; 21(1):41-4. PubMed ID: 9473545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nasolacrimal stent for epiphora caused by obstruction of the nasolacrimal duct].
    Posthuma BJ; van Imhoff WL; van Wezer JE
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):339-41. PubMed ID: 9132609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of complete obstruction of the nasolacrimal system by temporary placement of nasolacrimal polyurethane stents: preliminary results.
    Paúl L; Pinto I; Vicente JM
    Clin Radiol; 2003 Nov; 58(11):876-82. PubMed ID: 14581012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of polyurethane stent implantation for the treatment of complete obstruction of the nasolacrimal system: 8-month follow-up and complications].
    Anders N; Hoffmann KT; Hosten N; Walkow T; Felix R; Hartmann C
    Ophthalmologe; 1999 Oct; 96(10):658-62. PubMed ID: 10552159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of nasolacrimal duct obstruction with polyurethane stent placement: long-term results.
    Yazici Z; Yazici B; Parlak M; Tuncel E; Ertürk H
    AJR Am J Roentgenol; 2002 Aug; 179(2):491-4. PubMed ID: 12130461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsurgical placement of a nasolacrimal polyurethane stent: long-term effectiveness.
    Song HY; Jin YH; Kim JH; Suh SW; Yoon HK; Kang SG; Sung KB
    Radiology; 1996 Sep; 200(3):759-63. PubMed ID: 8756928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dacryocystostenting: technical and long-term results.
    Falappa P; Ortenzi M; Passarelli F; Micozzi M
    Radiol Med; 2006 Feb; 111(1):116-22. PubMed ID: 16623311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lacrimal duct stent for nasolacrimal duct obstruction].
    Xiao M; Jiang Y; Zhang Z
    Zhonghua Yan Ke Za Zhi; 2002 May; 38(5):289-91. PubMed ID: 12133376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasolacrimal polyurethane stent: complications with CT correlation.
    Pinto IT; Paul L; Grande C
    Cardiovasc Intervent Radiol; 1998; 21(6):450-3. PubMed ID: 9853160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of preoperative digital subtraction dacryocystography for nasolacrimal stent].
    Xiao MY; Huang PN; Zhang ZS
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):416-8. PubMed ID: 12206023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic endonasal dacryocystorhinostomy with ostial stent intubation following nasolacrimal duct stent incarceration.
    Wang X; Bian Y; Yan W; Daniel P; Tu Y; Wu W
    Curr Eye Res; 2015; 40(12):1185-94. PubMed ID: 25495271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.